The effect of dosage on the dexamethasone suppression test in normal controls. 1982

A J Rush, and M A Schlesser, and D E Giles, and G T Crowley, and C Fairchild, and K Z Altshuler

A sample of 23 drug-free, normal adult subjects, aged 23 to 50 years, received 1 mg dexamethasone p.o. at midnight. Serum cortisols were obtained at 0800h, 1600h, and 2330h pre- and postdexamethasone. Only 1 of these 23 subjects (4.3%) evidenced nonsuppression, as defined by any postdexamethasone serum cortisol value of greater than 4.0 micrograms/dl. A dose of 0.75 mg dexamethasone was administered to 23 drug-free, normal adult subjects, 20 of whom participated in the above 1 mg trial. Six of these 23 (26.1%) showed nonsuppression at a threshold of 4.0 micrograms/dl. Another 11 normal adults who were taking various prescription medications (e.g., sympathomimetics, nasal decongestants, birth control pills, thyroid hormones) or who were suffering from untreated upper respiratory infections, venereal infections, or allergies were tested with 1 mg of dexamethasone. In this sample, 7 of 13 (53.8%) showed nonsuppression. These findings suggest that: (1) 1 mg of dexamethasone is the lowest effective dose that can be used in diagnostic testing for melancholic depression; (2) a false-positive response to the dexamethasone suppression test (DST) may occur with infections, allergies, or possibly with certain prescription medications. Further studies of the effects of illness and/or medications on DST responses are needed.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D003866 Depressive Disorder An affective disorder manifested by either a dysphoric mood or loss of interest or pleasure in usual activities. The mood disturbance is prominent and relatively persistent. Depression, Endogenous,Depression, Neurotic,Depression, Unipolar,Depressive Syndrome,Melancholia,Neurosis, Depressive,Unipolar Depression,Depressions, Endogenous,Depressions, Neurotic,Depressions, Unipolar,Depressive Disorders,Depressive Neuroses,Depressive Neurosis,Depressive Syndromes,Disorder, Depressive,Disorders, Depressive,Endogenous Depression,Endogenous Depressions,Melancholias,Neuroses, Depressive,Neurotic Depression,Neurotic Depressions,Syndrome, Depressive,Syndromes, Depressive,Unipolar Depressions
D003907 Dexamethasone An anti-inflammatory 9-fluoro-glucocorticoid. Hexadecadrol,Decaject,Decaject-L.A.,Decameth,Decaspray,Dexasone,Dexpak,Hexadrol,Maxidex,Methylfluorprednisolone,Millicorten,Oradexon,Decaject L.A.
D003937 Diagnosis, Differential Determination of which one of two or more diseases or conditions a patient is suffering from by systematically comparing and contrasting results of diagnostic measures. Diagnoses, Differential,Differential Diagnoses,Differential Diagnosis
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006854 Hydrocortisone The main glucocorticoid secreted by the ADRENAL CORTEX. Its synthetic counterpart is used, either as an injection or topically, in the treatment of inflammation, allergy, collagen diseases, asthma, adrenocortical deficiency, shock, and some neoplastic conditions. Cortef,Cortisol,Pregn-4-ene-3,20-dione, 11,17,21-trihydroxy-, (11beta)-,11-Epicortisol,Cortifair,Cortril,Epicortisol,Hydrocortisone, (11 alpha)-Isomer,Hydrocortisone, (9 beta,10 alpha,11 alpha)-Isomer,11 Epicortisol
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

A J Rush, and M A Schlesser, and D E Giles, and G T Crowley, and C Fairchild, and K Z Altshuler
November 1985, Biological psychiatry,
A J Rush, and M A Schlesser, and D E Giles, and G T Crowley, and C Fairchild, and K Z Altshuler
January 1987, Psychoneuroendocrinology,
A J Rush, and M A Schlesser, and D E Giles, and G T Crowley, and C Fairchild, and K Z Altshuler
April 1985, Canadian journal of psychiatry. Revue canadienne de psychiatrie,
A J Rush, and M A Schlesser, and D E Giles, and G T Crowley, and C Fairchild, and K Z Altshuler
March 1985, Psychiatry research,
A J Rush, and M A Schlesser, and D E Giles, and G T Crowley, and C Fairchild, and K Z Altshuler
May 1983, The British journal of psychiatry : the journal of mental science,
A J Rush, and M A Schlesser, and D E Giles, and G T Crowley, and C Fairchild, and K Z Altshuler
March 1985, Psychiatry research,
A J Rush, and M A Schlesser, and D E Giles, and G T Crowley, and C Fairchild, and K Z Altshuler
June 1989, Canadian journal of psychiatry. Revue canadienne de psychiatrie,
A J Rush, and M A Schlesser, and D E Giles, and G T Crowley, and C Fairchild, and K Z Altshuler
January 1988, Biological psychiatry,
A J Rush, and M A Schlesser, and D E Giles, and G T Crowley, and C Fairchild, and K Z Altshuler
September 1981, The American journal of psychiatry,
A J Rush, and M A Schlesser, and D E Giles, and G T Crowley, and C Fairchild, and K Z Altshuler
September 1982, Lancet (London, England),
Copied contents to your clipboard!